Outcomes in patients with aggressive B‐cell non‐Hodgkin lymphoma after intensive frontline treatment failure
Sign Up to like & getrecommendations! Published in 2019 at "Cancer"
DOI: 10.1002/cncr.32526
Abstract: Salvage immunochemotherapy followed by high‐dose chemotherapy and autologous stem cell transplantation is the standard‐of‐care second‐line treatment for patients with relapsed/refractory diffuse large B‐cell lymphoma after first‐line R‐CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone). Outcomes after… read more here.
Keywords: patients aggressive; lymphoma; aggressive cell; line ... See more keywords
Predictors and management of relapse to axicabtagene ciloleucel in patients with aggressive B-cell lymphoma.
Sign Up to like & getrecommendations! Published in 2021 at "Hematology/oncology and stem cell therapy"
DOI: 10.1016/j.hemonc.2021.09.001
Abstract: OBJECTIVE/BACKGROUND Despite the success of chimeric antigen receptor (CAR) T-cell therapy in patients with aggressive non-Hodgkin lymphoma (aNHL), some patients still fail treatment, and their prognosis is dismal. METHODS We performed a retrospective study of… read more here.
Keywords: axicabtagene ciloleucel; patients aggressive; axi cel; therapy ... See more keywords
C-reactive protein in patients with aggressive periodontitis
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Dental Sciences"
DOI: 10.1016/j.jds.2017.04.003
Abstract: Background/purpose The aim of this study was to evaluate and compare the systemic levels of C-reactive protein (CRP) in peripheral blood samples of patients with aggressive periodontitis during the first twelve months of periodontal treatment,… read more here.
Keywords: protein; patients aggressive; aggressive periodontitis; periodontal treatment ... See more keywords
Outcome after high‐dose chemotherapy and autologous stem cell transplantation in patients with aggressive B‐cell non‐Hodgkin's lymphoma
Sign Up to like & getrecommendations! Published in 2018 at "European Journal of Haematology"
DOI: 10.1111/ejh.13064
Abstract: For more than two decades, high‐dose chemotherapy (HDT) and autologous blood stem cell transplantation (ABSCT) were treatment options for patients with aggressive B‐cell non‐Hodgkin's lymphoma (B‐NHL). However, the ideal timing and the collective patient benefits… read more here.
Keywords: patients aggressive; dose chemotherapy; high dose; cell transplantation ... See more keywords
The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells.
Sign Up to like & getrecommendations! Published in 2019 at "Blood"
DOI: 10.1182/blood-2018-11-887067
Abstract: Factors associated with durable remission after CD19 chimeric antigen receptor (CAR)-modified T-cell immunotherapy for aggressive B-cell non-Hodgkin lymphoma (NHL) have not been identified. We report multivariable analyses of factors affecting response and progression-free survival (PFS)… read more here.
Keywords: patients aggressive; response; pfs patients; favorable cytokine ... See more keywords
Polypharmacy and potentially inappropriate medication use in older patients with aggressive non-Hodgkin lymphoma (NHL) leads to inferior survival and increased treatment-related toxicities.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.10039
Abstract: 10039Background: Survival outcomes for older patients with aggressive NHL are disproportionally inferior to those of younger patients. While differences in tumor biology may play a role, older pati... read more here.
Keywords: patients aggressive; medication use; inappropriate medication; older patients ... See more keywords
Outcomes in minority patients (pt) with aggressive B cell lymphoma (BCL) if optimally managed with equal access to care and nurse navigation (NN).
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.e19040
Abstract: e19040Background: Aggressive BCL is curable but previous studies have shown that minorities have inferior survival, partly due to socioeconomic barriers and poor access to care. NN programs are des... read more here.
Keywords: patients aggressive; access care; outcomes minority; access ... See more keywords
Association of social support with overall survival and health care utilization in patients with aggressive hematologic malignancies.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.15_suppl.e18582
Abstract: e18582 Background: Social support plays a crucial role for patients with aggressive hematologic malignancies as they navigate their illness course. We examined associations of social support with overall survival and health care utilization in this… read more here.
Keywords: social support; patients aggressive; aggressive hematologic; hematologic malignancies ... See more keywords